TY - JOUR
T1 - The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study
AU - Yoel, Uri
AU - Alkobi Weiss, Hadar
AU - Goldbart, Adi
AU - Silverman Siris, Ethel
AU - Fisher, David Louis
AU - Hassan, Lior
AU - Fraenkel, Merav
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2025/2/1
Y1 - 2025/2/1
N2 - Summary: The implementation of an in-hospital fracture liaison service facilitated prompt initiation of anti-osteoporosis treatment following a hip fracture (HF), increasing follow-up and treatment rates. This led to a 48% reduction in the risk of subsequent HF and a 29% decrease in mortality rates. Purpose: To demonstrate the impact of an institutional fracture liaison service (FLS) which allowed in-hospital anti-osteoporosis treatment following hip fracture (HF) on subsequent HF and mortality rate. Methods: We retrospectively evaluated patients aged 65 years and older, admitted with an osteoporotic HF, who were transferred following surgery for rehabilitation in the geriatrics department in two time periods: before and after the implementation of an institutional FLS (“geriatric-pre-FLS” and “geriatric-FLS” cohorts, respectively). Data were captured from electronic records and the two cohorts were compared following an assessment of baseline characteristics, follow-up, and anti-osteoporosis treatment initiation. A multivariable Cox regression model evaluated differences between the cohorts regarding subsequent HF and mortality rates. Results: Three hundred and eighteen and 448 patients comprised the geriatric-pre-FLS (07/2008–06/2014) and the geriatric-FLS (03/2016–03/2020) cohorts, respectively. Baseline characteristics were comparable between the cohorts (median age 81 vs. 82, p = 0.08 and female sex 73% vs. 70%, p = 0.48, respectively). Rates of endocrine consultation (3.5% vs. 99%%, p < 0.001), DXA-BMD testing (7.5% vs. 34%, p < 0.001), and parenteral anti-osteoporosis treatment (4% vs. 76.6%, p < 0.001) were all higher in the geriatric-FLS cohort. The implementation of the FLS led to a 48% reduction in subsequent HF risk (HR 0.52; 95% CI 0.37–0.74, p < 0.001) and a 29% decrease in mortality rate (HR 0.71; 95% CI 0.54–0.92, p = 0.011). Conclusions: The implementation of an in-hospital FLS facilitated prompt initiation of anti-osteoporosis treatment following a HF, increased follow-up and treatment rates, and resulted in a 48% reduction in subsequent HF risk and a 29% reduction in mortality rates.
AB - Summary: The implementation of an in-hospital fracture liaison service facilitated prompt initiation of anti-osteoporosis treatment following a hip fracture (HF), increasing follow-up and treatment rates. This led to a 48% reduction in the risk of subsequent HF and a 29% decrease in mortality rates. Purpose: To demonstrate the impact of an institutional fracture liaison service (FLS) which allowed in-hospital anti-osteoporosis treatment following hip fracture (HF) on subsequent HF and mortality rate. Methods: We retrospectively evaluated patients aged 65 years and older, admitted with an osteoporotic HF, who were transferred following surgery for rehabilitation in the geriatrics department in two time periods: before and after the implementation of an institutional FLS (“geriatric-pre-FLS” and “geriatric-FLS” cohorts, respectively). Data were captured from electronic records and the two cohorts were compared following an assessment of baseline characteristics, follow-up, and anti-osteoporosis treatment initiation. A multivariable Cox regression model evaluated differences between the cohorts regarding subsequent HF and mortality rates. Results: Three hundred and eighteen and 448 patients comprised the geriatric-pre-FLS (07/2008–06/2014) and the geriatric-FLS (03/2016–03/2020) cohorts, respectively. Baseline characteristics were comparable between the cohorts (median age 81 vs. 82, p = 0.08 and female sex 73% vs. 70%, p = 0.48, respectively). Rates of endocrine consultation (3.5% vs. 99%%, p < 0.001), DXA-BMD testing (7.5% vs. 34%, p < 0.001), and parenteral anti-osteoporosis treatment (4% vs. 76.6%, p < 0.001) were all higher in the geriatric-FLS cohort. The implementation of the FLS led to a 48% reduction in subsequent HF risk (HR 0.52; 95% CI 0.37–0.74, p < 0.001) and a 29% decrease in mortality rate (HR 0.71; 95% CI 0.54–0.92, p = 0.011). Conclusions: The implementation of an in-hospital FLS facilitated prompt initiation of anti-osteoporosis treatment following a HF, increased follow-up and treatment rates, and resulted in a 48% reduction in subsequent HF risk and a 29% reduction in mortality rates.
KW - Fracture liaison services (FLS)
KW - Hip fracture
KW - Mortality
KW - Osteoporosis
KW - Subsequent hip fracture
UR - http://www.scopus.com/inward/record.url?scp=85212440129&partnerID=8YFLogxK
U2 - 10.1007/s00198-024-07325-9
DO - 10.1007/s00198-024-07325-9
M3 - Article
C2 - 39694923
AN - SCOPUS:85212440129
SN - 0937-941X
VL - 36
SP - 299
EP - 309
JO - Osteoporosis International
JF - Osteoporosis International
IS - 2
ER -